Use of nicotinic acid adenine dinucleotide phosphate or derivative thereof as agent for treating type-2 diabetes

摘要

The administration of nicotinic acid adenine dinucleotide phosphate (NAADP) or a pharmaceutically acceptable salt thereof to a host in need thereof for the treatment of type-2 diabetes has been disclosed.